Partnership Seeks to Lower Costs of COPD Meds

Partnership Seeks to Lower Costs of COPD Meds

302616

Partnership Seeks to Lower Costs of COPD Meds

GoodRx, a platform for healthcare savings in the U.S., and pharmaceutical company Boehringer Ingelheim have teamed up to help lower out-of-pocket medication costs  for people with chronic obstructive pulmonary disease (COPD) or type 2 diabetes. Patients will be able to enroll in sponsored copay programs to access  Boehringer Ingelheim’s lead medications at lower costs, with the possibility of accessing more medications in the future. According to GoodRx, the new partnership may result in consumer savings of…

You must be logged in to read/download the full post.